Chicago Partners Investment Group LLC raised its holdings in The Goldman Sachs Group, Inc. (NYSE:GS – Free Report) by 4.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,212 shares of the investment management company’s stock after purchasing an additional 53 shares during the quarter. Chicago Partners Investment Group LLC’s holdings in The Goldman Sachs Group were worth $627,000 as of its most recent filing with the SEC.
Other institutional investors also recently bought and sold shares of the company. Procyon Advisors LLC increased its stake in The Goldman Sachs Group by 5.5% in the third quarter. Procyon Advisors LLC now owns 830 shares of the investment management company’s stock valued at $411,000 after purchasing an additional 43 shares during the period. Brookstone Capital Management raised its holdings in The Goldman Sachs Group by 19.9% during the third quarter. Brookstone Capital Management now owns 4,582 shares of the investment management company’s stock worth $2,268,000 after purchasing an additional 761 shares in the last quarter. Empowered Funds LLC raised its holdings in The Goldman Sachs Group by 62.7% during the first quarter. Empowered Funds LLC now owns 6,301 shares of the investment management company’s stock worth $2,632,000 after purchasing an additional 2,428 shares in the last quarter. Duality Advisers LP purchased a new position in The Goldman Sachs Group during the first quarter worth about $1,388,000. Finally, BI Asset Management Fondsmaeglerselskab A S raised its holdings in The Goldman Sachs Group by 34.2% during the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 8,256 shares of the investment management company’s stock worth $3,448,000 after purchasing an additional 2,103 shares in the last quarter. 71.21% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at The Goldman Sachs Group
In other The Goldman Sachs Group news, insider Brian J. Lee sold 2,000 shares of The Goldman Sachs Group stock in a transaction on Thursday, October 17th. The shares were sold at an average price of $530.90, for a total value of $1,061,800.00. Following the transaction, the insider now owns 10,095 shares in the company, valued at $5,359,435.50. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.54% of the stock is owned by company insiders.
The Goldman Sachs Group Stock Down 1.5 %
The Goldman Sachs Group (NYSE:GS – Get Free Report) last announced its earnings results on Tuesday, October 15th. The investment management company reported $8.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.89 by $1.51. The firm had revenue of $12.70 billion for the quarter, compared to analyst estimates of $11.77 billion. The Goldman Sachs Group had a net margin of 9.89% and a return on equity of 11.05%. The Goldman Sachs Group’s revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the business earned $5.47 earnings per share. As a group, sell-side analysts anticipate that The Goldman Sachs Group, Inc. will post 37.14 earnings per share for the current year.
The Goldman Sachs Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, December 30th. Shareholders of record on Monday, December 2nd will be issued a $3.00 dividend. The ex-dividend date is Monday, December 2nd. This represents a $12.00 dividend on an annualized basis and a dividend yield of 2.35%. The Goldman Sachs Group’s dividend payout ratio (DPR) is presently 35.21%.
Wall Street Analysts Forecast Growth
Several research analysts recently issued reports on the stock. Citigroup increased their price target on shares of The Goldman Sachs Group from $460.00 to $485.00 and gave the stock a “neutral” rating in a report on Tuesday, July 16th. JMP Securities increased their price target on shares of The Goldman Sachs Group from $525.00 to $550.00 and gave the stock a “market outperform” rating in a report on Wednesday, October 9th. Oppenheimer increased their target price on shares of The Goldman Sachs Group from $577.00 to $614.00 and gave the company an “outperform” rating in a report on Wednesday, October 16th. Barclays increased their target price on shares of The Goldman Sachs Group from $565.00 to $588.00 and gave the company an “overweight” rating in a report on Wednesday, October 16th. Finally, Wells Fargo & Company increased their target price on shares of The Goldman Sachs Group from $504.00 to $550.00 and gave the company an “overweight” rating in a report on Tuesday, July 16th. Five analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $524.69.
Read Our Latest Stock Analysis on The Goldman Sachs Group
The Goldman Sachs Group Company Profile
The Goldman Sachs Group, Inc, a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements.
Read More
- Five stocks we like better than The Goldman Sachs Group
- The Significance of Brokerage Rankings in Stock Selection
- Intel: Is Now the Time to Be Brave?Â
- Best Stocks Under $5.00
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What is the Shanghai Stock Exchange Composite Index?
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for The Goldman Sachs Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Goldman Sachs Group and related companies with MarketBeat.com's FREE daily email newsletter.